Is Gossamer Bio Inc. (GOSS) positioned for future growth?

Gossamer Bio Inc. (NASDAQ: GOSS) stock jumped 2.46% on Monday to $0.94 against a previous-day closing price of $0.92. With 4.52 million shares changed hands, the volume of the stock remained heavier than its average volume of 2.45 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $0.9572 whereas the lowest price it dropped to was $0.8666. The 52-week range on GOSS shows that it touched its highest point at $13.83 and its lowest point at $0.84 during that stretch. It currently has a 1-year price target of $5.31. Beta for the stock currently stands at 1.20.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.

Sponsored

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of GOSS was down-trending over the past week, with a drop of -2.78%, but this was down by -7.55% over a month. Three-month performance dropped to -34.51% while six-month performance fell -1.88%. The stock lost -93.18% in the past year, while it has lost -56.54% so far this year. A look at the trailing 12-month EPS for GOSS yields -2.21 with Next year EPS estimates of -0.96. For the next quarter, that number is -0.26. This implies an EPS growth rate of 13.30% for this year and 29.40% for next year.

Float and Shares Shorts:

At present, 225.32 million GOSS shares are outstanding with a float of 220.17 million shares on hand for trading. On Aug 30, 2023, short shares totaled 19.77 million, which was 8.78% higher than short shares on Jul 30, 2023. In addition to Mr. Faheem Hasnain as the firm’s Co-Founder, CEO, Pres & Chairman, Mr. Bryan Giraudo serves as its COO & CFO.

Institutional Ownership:

Through their ownership of 90.37% of GOSS’s outstanding shares, institutional investors have majority control over the company. Other institutions hold 7.76% of GOSS, in contrast to 4.39% held by mutual funds. Shares owned by individuals account for 20.35%. As the largest shareholder in GOSS with 2.21% of the stake, HHLR Advisors Ltd. holds 4,974,041 shares worth 4,974,041. A second-largest stockholder of GOSS, Millennium Management LLC, holds 4,207,077 shares, controlling over 1.87% of the firm’s shares. Octagon Capital Advisors LP is the third largest shareholder in GOSS, holding 3,958,069 shares or 1.76% stake. With a 1.01% stake in GOSS, the Vanguard Total Stock Market ETF is the largest stakeholder. A total of 2,273,739 shares are owned by the mutual fund manager. The Vanguard Extended Market Index Fu, which owns about 0.50% of GOSS stock, is the second-largest Mutual Fund holder. It holds 1,124,386 shares valued at 1.17 million. T Rowe Price Health Sciences Fund holds 0.46% of the stake in GOSS, owning 1,039,680 shares worth 1.08 million.


An Overview of Recent Financials:

Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on Jun 29, 2023, GOSS reported revenue of $0.00 and operating income of -$53.86M. The EBITDA in the recently reported quarter was -$51.87M and diluted EPS was -$0.74.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for GOSS since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With GOSS analysts setting a high price target of $15.00 and a low target of $1.25, the average target price over the next 12 months is $5.31. Based on these targets, GOSS could surge 1495.74% to reach the target high and rise by 32.98% to reach the target low. Reaching the average price target will result in a growth of 464.89% from current levels.


EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy.

Summary of Insider Activity:

Insiders traded GOSS stock several times over the past three months with 3 Buys and 1 Sells. In these transactions, 607,700 shares were bought while 1,814 shares were sold. The number of buy transactions has increased to 9 while that of sell transactions has risen to 8 over the past year. The total number of shares bought during that period was 1,609,772 while 42,236 shares were sold.

Leave a Comment

Your email address will not be published. Required fields are marked *